The reanalysis of both NSCLC [44] and CRC [65] scRNA-seq T-cell dataset highlights that, in addition to its expression on conventional CD8+ and CD4+ T cells, the CXCR3 gene is expressed at a higher level on Tregs in the TME compared to NAT and PBMC (Figure 2), suggesting a specific recruitment in the TME. The gene discussed is BRD2; the disease is non-small cell lung carcinoma.